Forum Agenda

Advanced Stem Cell Culture Process Symposium

Stay tuned

Moderator:Shang Xiao,Founder & Chairman, Youyi Bio

 

Culture of MSC: from 2D to 3D, and beyond

Lianming Liao:CSO, Tuohong Bio

 

High-Efficiency Exosome Production Factory Driven by All-Factor Integrated Medium

Ali Mohsin:VP of R&D, Youyi Bio

 

Roundtable 1: Implementation of Documents No. 818 and No. 828 – Risks and Challenges in Cell Therapy Supply Chain under Dual Regulatory Frameworks

Yutian Shen: CEO, Saijun Bio

Zhiying He: Distinguished Researcher & Executive Director,Institute for Regenerative Medicine,Shanghai East Hospital of Tongji University

Yonghong Yin: Deputy GM, Sailiwei Bio

Yijie Yang: Co-founder & CEO, Shenzhen Huixin Bio-Medical Technology Co., Ltd.

Yueming Wang: CEO, Yuanxin Excellence Bio; International Advisor, Beijing Daxing International Airport Economic Zone

Ting Zhang: CEO, Gemrisen

 

Roundtable 2: Compliance and Prospects of MSC Cell Therapy

Wei Wu(Moderator): General Manager, Suzhou Youyi Bio

Chencai Liu: Deputy GM, Qichuang Research Institute

Lin Shi: Chief Medical Officer, Jinfeng Laboratory; former VP of Yuanda Medical; Vice Chairperson, CBIITA Consortium; Professor

Guanghua Yang: Chief Scientist, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; Chairman, Heji (Shanghai) Medical Technology Co., Ltd.

Zhang Wenjun: Deputy Director, Institute of Hematology, Tongji University; Deputy Director, Oncology Center, Tongji Hospital; Deputy Director, Institute of Hematology, Tongji University School of Medicine

PAN SWEE TING: Managing Director & Head of China, JIF Capital